General
Preferred name
BROMOPRIDE
Synonyms
Bromoprida ()
Valopride ()
Artomey ()
NSC-758391 ()
Movipride ()
P&D ID
PD001072
CAS
4093-35-0
3963-95-9
Tags
available
drug
First approval
1976
Drug Status
approved
investigational
Max Phase
3.0
Drug indication
Dyspepsia
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Bromopride is a dopamine antagonist with prokinetic properties, widely used as an antiemetic.
PRICE 72
DESCRIPTION Bromopride (Valopride) is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic. It is not available in the United States or the United Kingdom. (TargetMol Bioactive Compound Library)
Compound Sets
12
Cayman Chemical Bioactives
29329
ChEMBL Drugs
CHEMBL399510
Drug Repurposing Hub
DrugBank
DB09018
DrugCentral
406
DrugCentral Approved Drugs
406
MedChem Express Bioactive Compound Library
HY-B1164
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
T1175
The Spectrum Collection
External IDs
28
Properties
(calculated by RDKit )
Molecular Weight
343.09
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
7
Ring Count
1
Aromatic Ring Count
1
cLogP
2.11
TPSA
67.59
Fraction CSP3
0.5
Chiral centers
0.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
dopamine
DRD2
Dopamine Receptor
Indication
nausea, vomiting, gastroesophageal reflux disease (GERD)
MOA
Dopamine Receptor antagonist
Pathway
GPCR/G protein
Neuronal Signaling
Neuroscience
Source data